What Your Clients Pay For Next

Every commercial director at a mid-market research firm in Europe has had the same Monday morning this year. The Q1 renewals call ran long. A three-year client wanted 20% less budget for the same scope. Their reason: the internal team is using AI for the first pass now. Another client paused the subscription entirely. A third renewed, but asked what you would actually deliver in 2027 that their own team could not produce. Your best senior analyst mentioned a call from a competitor on Friday. Your proposal pipeline on advisory work is flat. Your CEO asked on Monday morning what the renewal book looks like at Q3.

You have done this job for fifteen years. The pattern used to be simple. Do good work. Publish credible research. Sit across from a CFO or a Head of Strategy and make the case for twelve more months. Retention stayed above ninety. The advisory book grew off the subscription base. The business was understandable.

Something changed. The work you used to sell is work your clients now produce themselves. Your marketing is still running the report-launch playbook against clients who search in Perplexity and Claude. Your proposal language still describes deliverables. Your best analysts are watching AI-native firms at half your price land on accounts you thought were safe. And under all of it, twenty years of your firm's sector work is sitting in shared drives and senior heads, never organised into anything the market can buy.

This is not a you problem. It is an industry problem and a function problem happening at the same time. Most research commercial directors are treating them as two. The ones who see them as one are going to own the next decade of specialist intelligence work.

This briefing covers what is happening in your industry, what it means for your renewals book and your advisory pipeline, and the three questions your leadership team should answer before the next board cycle.

For forty years the deal between specialist research firms and their clients was simple. Gathering and synthesising information at the quality your clients needed was expensive enough to justify outsourcing. Your analysts knew the sector, held the methodology, and maintained the data. Your clients paid an annual subscription or a project fee because doing the work themselves cost more. The product was the information, and the price was a function of how hard it was to produce. Every research firm has priced on that basis since the 1980s.

AI does not sit inside that equation. Secondary research, market sizing, competitive scanning, literature review, data aggregation, the structured analysis that fills the middle of a report — all of it is now AI-executable at near-zero marginal cost. Your clients have discovered this. They are running the first-pass analysis themselves in half a morning with a general-purpose AI tool, and they are getting something that looks a lot like what you used to send them. The part they used to pay for because it was expensive is no longer expensive. That is the quiet end of a forty-year commercial model.

Your clients' internal teams are producing the part of the work you used to charge for. Your subscription price floor is not being negotiated in your renewals call. It is being set before your account director walks in.

The AI-native entrants know this. They are pricing at half your rate because they do not have an analyst base to protect, and they can ship a usable product in six months because their cost base was built AI-first. The reference case your peers read in the trade press is Bisnode being absorbed into Dun & Bradstreet. The next reference case will be a boutique research firm that waited eighteen months and woke up to find its top-twenty accounts renewed at half-scope. The defensive stance (lower your price, cut analyst cost, run the old motion cheaper) is the deflationary spiral your CFO is already modelling. The winning firms are running a different motion: a different product sold under the wrapper of the old relationships, at a margin the old subscription never carried.

Your renewals book. Your account directors are walking into calls where the client has already priced your subscription against internal AI. They ask for scope cuts you never used to see. They pause on a three-year relationship and tell you they want to see what the team can do alone. The directors who hold the renewal are the ones who walk in with something the client's AI tool did not produce. The ones who defend the old scope at the old price are losing a percentage of the book every quarter, and the percentage is compounding.

Your proposals on advisory work. Your proposal hit rate on advisory expansion used to be your margin engine. It is flat or down. Your proposal language still describes research deliverables in methodology language a client can now get from a generalist tool. What clients actually buy in 2026 is the contrarian reading your senior analysts have on their sector, and the proposals that close are the ones that already show the insight rather than promising it. Most of your proposals do not.

Your marketing team. The report-launch playbook is ten years old and the audience changed under it. Buyers no longer read the quarterly sector report as a ritual. They search in answer engines and they ask the tool what your firm has published. If your firm does not show up in those answers, you are not in the client's mental model. The leading firms are shifting marketing from publication calendar to authority engine. Original research that answer engines cite. Senior analyst voices in industry press. Research the AI-native entrants cannot replicate because they do not have your firm's twenty years of client work underneath it. Marketing's job is becoming the surface layer on the firm's proprietary asset, not a campaign calendar.

Your best analysts. Your senior analysts are the people who make the firm worth paying for. They also know exactly what is happening to the business. The AI-native firms are calling them with founding-team offers and equity. Your competitors' commercial leaders are hiring your directors with double their current comp because the directors come with client relationships. Your senior bench is a retention problem for the first time in ten years. The firms that keep their best senior people are the ones giving them a new instrument to play. The ones still pointing their senior analysts at the old deliverables are losing them to firms offering a product they actually want to build.

Your best people's knowledge. Your top three senior analysts carry twenty years of sector pattern recognition, methodology intuition, client political memory, and contrarian-reading history in their heads. None of it has ever been written down in a form that survives their departure. Two of your top three are over fifty-five. When they leave, the judgment that made the firm worth the premium leaves with them. The industry has never had a way to fix this. In 2026 it does, but only if you move before the retirement conversations land.

Your industry is compressing because AI takes the research-production work out of the subscription. Your function is compressing because your account directors walk into renewals with clients already armed. Same force, two altitudes. But there is a third thing happening that most research commercial directors have not named yet, and it is the one that matters most.

Look at the research firms pulling ahead. They are not defending the old subscription at a lower price. They are organising twenty years of their own client work — every project file, every methodology record, every sector benchmark, every analyst note — into a queryable asset that becomes the basis of a new product. The subscription wrapper stays. Inside the wrapper, the client is buying access to something the AI-native entrant cannot replicate for eighteen months: your firm's actual accumulated sector thinking, available as an instrument their team uses. The senior advisory sits on top at a higher rate. The proposal pitches show a working demo built from the asset against the client's own situation. The whole commercial motion runs on the asset, not on research production.

Most research commercial directors are still running the old motion. A quality push on deliverables. A tool evaluation for analyst productivity. A rebrand of the subscription tier. Twelve months later the book keeps bleeding, because the old motion was built for an economy where production was expensive. Production is no longer expensive. What you have accumulated is.

You have twelve to eighteen months. The AI adoption debate is over. Your question now is whether you lead the product migration yourself, or the CEO hires someone who will.

Most research commercial directors have made the same four decisions this year. A smaller group is making different ones. The difference is whether the response is defend-and-cut on the old product, or migrate to a new one the old relationships can still buy.

Three questions every research commercial director is tracking. None of them used to be the same question. They are now.

Four concrete moves any commercial director can start this quarter. Each touches one function. Pulled together, they migrate the firm from a subscription-on-information motion to an access-on-asset motion.

The commercial director of a research firm in 2026 has four places to go for help. None of them can do what we do, and each for a specific reason.

The incumbent research-platform vendors will sell you a bigger platform subscription. They cannot build a custom product on your methodology because their platform economics require scale. They are three years from AI-native entrants eating their entry tier, and they know it.

The big consulting firms will write you a two-million-euro strategy deck. They cannot put a working insight tool in your analysts' hands in three weeks because their billing requires analyst hours. You get the deck or the tool. You cannot have both.

The AI-native research startups sell a tool that produces faster output. They have no access to your twenty years of proprietary sector work, and they do not understand the contrarian-insight conversation your senior analysts have with a C-suite. A product, not a capability.

Telling your analysts to use ChatGPT more produces faster deliverables. It produces zero change in the commercial motion. Your clients still cancel because the output is the thing they already chose not to buy.

The market offers four things you have already said no to. GRAIL is the fifth option.

We start with your commercial leadership team because the change cannot outrun the team's personal understanding of what is possible. Three workshops. Each delivers standalone value. Each earns the right to the next.

The questions where your leadership team cannot agree are the ones worth an hour on the agenda. Ask these honestly.